protection or, alternatively, measurement of the antibody appearing in the animals' sera. Vaccines are considered to pass such tests if an arbitrary proportion of the animals is protected from the challenge or an arbitrary mean level of antibody is evoked. Such 'pass or fail' tests, however, can very readily provide different results in different experimental circumstances, as they are, by their very format, completely uncontrolled. As a consequence of such irregularities, statistically-based assays are now being increasingly adopted. The 3 + 3 quantal assay technique, in which three groups of animals are immunized each with one of three concentrations of a standard vaccine, and three groups are immunized each with one of three concentrations of the test vaccine prior to subsequent challenge with the appropriate pathogen, has long been used for the potency assay of whooping-cough vaccine and is soon to be required by the European Pharmacopoeia for that of absorbed diphtheria and tetanus vaccines. This form of assay has great advantages over the 'pass or fail' type of test, in that comparison of the percentages of survivors in the groups of animals by the technique of probit analysis provides not only an. estimate of the potency of the test vaccine in terms of the standard but, in addition, the confidence limits of that estimate.
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Assay ofsensitizing potency: Lastly, and uniquely in the quality control of BCG vaccine, is the use of animals to demonstrate the development of immunity through the mediation of delayed hypersensitivity. In this test, BCG-vaccinated guinea-pigs are challenged with an intradermal dose of tuberculin and the development of a reaction of delayed hypersensitivity, a Mantoux type reaction, is observed 24 hours later. Development of the reaction is indicative of a vaccine of adequate potency.
Taken together the tests in animals used in the quality control of vaccines serve many purposes for which there are at present no acceptable alternatives and, although the number of basic procedures is quite small, adaptations of these to the circumstances of individual vaccines can provide very firm assurances of the identity, the safety, and the efficacy of most vaccines. About a century ago George Eliot caused one of her characters to observe that 'animals are such agreeable friends, they ask no questions. . .' If she were writing today she might well extend that observation by adding that they nevertheless provide many answers. In a symposium on the validity of tests in laboratory animals a paper on cell cultures may be thought anomalous. The use of cell cultures as a substitute for animals in the preparation and testing of vaccines can be considered of interest. The control of vaccines demands tests to establish their safety and potency; these tests have their sanction in the performance of the vaccine in the field.
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The problems that require solution by the testing procedures are slightly different for killed and for attenuated living vaccine. For a killed vaccine, it is necessary to establish by suitable tests that all the infectious agent has been destroyed, but that there is sufficient antigen left to establish immunity. There is another problem for both types of vaccine, namely, establishing that the vaccine does not contain any other living agent derived from the seed, the cells used to propagate viruses or the serum used to nourish them. For living virus vaccines it is necessary to establish that there are no extraneous agents present, that the virus remains sufficiently attenuated and that there is sufficient living virus present in the vaccine.
Although cell cultures have been used for testing the activity of diphtheria toxin and its antitoxin, space does not permit the examination of this problem.
Nowadays, viral vaccines with few exceptions are made from viruses propagated in fertile eggs (hens) or in cells in culture. A few vaccines are still made in animal tissues: orf vaccine is still made from the scabs produced on infected sheep; most smallpox vaccine has been prepared on the skin of calves or sheep and has played a crucial role in the elimination of smallpox from nearly all the countries of the world; and until recently, rabies and foot and mouth vaccines have been made in animal tissues rather than cell cultures.
For various reasons living virus vaccines are still the most used variety, but there are some very important killed vaccines. Perhaps the most widely used is killed vaccine for the control of foot and mouth disease; this is nowadays most often prepared in suspension cultures of baby hamster kidney cells (BHK 21). It is inactivated with acetylethyleneimine (AEI) which produces a linear inactivation of adequately pure filtered and non-aggregated virus. The first problem for killed vaccine production is to produce adequate amounts of the protective antigen and it is this that has been triumphantly achieved for foot and mouth vaccine, which can be grown in 1000 litre or larger fermentors ( Figure 1 ). Similarly, highly purified killed influenza vaccine is grown in fertile eggs. The influenza virus is readily inactivated by means of formalin, but there are other extraneous viruses, notably avian leucosis viruses, present in commercial, fertile eggs used for vaccine production, and tests for the inactivation of these have to be done as well. Recently-killed poliovaccine has been coming back into the news again as a result of ardent adv-ocacy by Salk & Salk (1977) , and it illustrates well some of the problems in the use of cell cultures for testing vaccines. First, what sort of cells should be used for virus propagation? At present poliovirus for killed vaccine is grown in monkey kidney cultures, but about 50O% of these contain extraneous viruses even after a period of at least eight weeks in quarantine. Moreover, one of the viruses prevalent in Rhesus monkey kidney cell cultures, SV40, is not inactivated reliably by the formalin treatment normally used. Alternative cell cultures are human diploid cells, W138 or MRC5, or a continuous cell capable of growing in suspension culture, for example, Hela cells or Vero cells derived from Vervet monkey kidney. Human diploid cells are well established for vaccine production, but their requirement of a surface to spread out on creates technological difficulties for large-scale production for a killed vaccine where virus concentration and purification is required. This is quite unlike the circumstances of living vaccine production, where diploid cells have been widely and successfully used, because most living vaccines can be diluted for use. These difficulties seem likely to make a killed vaccine made in this way less economic than that made from cells grown in suspension. Continuous cell lines that will grow in suspension are now not favoured for vaccine production, but it is hard to see sound scientific reasons for not using them and to deny a source of abundant viral antigen that can be chemically purified. The degree of purity can be checked by analytical techniques, for example, by acrylamide gel electrophoresis. This technique is used to follow the purity of killed influenza vaccine and the same technique can be applied to poliovirus, and only the polypeptides of the virus are seen in purified preparations.
A second problem is to ensure that all the protective antigens are present and in adequate amounts. There have been some notable failures of killed vaccine due to the absence of an essential protective antigen. Thus, killed vaccinia virus made from intracellular virus lacks a crucial antigen present in extracellular virus. Similarly, killed measles vaccines lack the haemolysin component of the envelope and only contain haemagglutinin. This is very probably the reason why killed measles vaccines are less effective in the prevention of the disease and can give rise to a hypersensitivity to measles virus. A more recent example is the killed New Jersey swine influenza vaccine made in the USA. This lacked the neuraminidase component of the virus envelope and would probably have been less effective than a vaccine containing both neuraminidase and haemagglutinin, such as that produced in Britain.
The tests for residual living virus were first adequately considered for killed poliovirus vaccines in the wake of the Cutter disaster, when 260 cases and 10 deaths occurred due to the presence of live poliovirus in killed vaccine (Nathanson & Langmuir 1963 ). The first lesson was that the first order kinetics of inactivation prevailing in the first few hours could not safely be projected forward. (The situation is different for foot and mouth disease inactivated by AEI, where experience has shown that the extrapolation is valid.) The second point was that the samples to be tested should not be proportional to batch size, for example 5%. The chance of detecting low level contamination is related to the absolute size of the sample, not to its proportion of the whole. As a result, a requirement was made for testing three 500 ml samples. Before this, smaller quantities were often tested. It is still sometimes erroneously recommended that a proportion of a vaccine lot should be tested, without a large enough minimum amount. The practical size of sample capable of being tested is always very small in relation to the chance of detecting low level contamination, and it is for this reason that so much emphasis came to be placed on the consistency of the total manufacturing process.
As a result of a number of tests carried out after the Cutter incident (Nathanson & Langmuir 1963) it was concluded that, despite the superiority of tissue culture tests for -detecting poliovirus, monkeysespecially cortisone-treated onesinoculated directly into the central nervous system were more sensitive to poliovirus which had been partially inactivated with formalin than to cell cultures. These results were based on efforts to detect such damaged poliovirus in cell cultures and animals. When I was working on killed poliovaccine, it was found by contrast that tissue cultures were more sensitive than monkeys. Living poliovirus was detected in some monovalent lots of killed poliovaccine during the course of manufacture. In this experience there was an extremely low level of contamination. Moreover, it was only detected in tissue culture and not in monkeys. A characteristic feature was the appearance of the virus after at least 21 days of incubation in the original vessels. Also the incidence of positive cultures did not increase over the six-day period when the three 500 ml quantities of virus were taken. The infection was related to the filtration process; it first occurred when glass filters were used and persisted when they were changed to Seitz EKS 1, and was finally resolved by using EKS2 pads in a specially designed filter holder and applying special control procedures to assure the quality of filter pads. For foot and mouth disease too, tissue cultures are a better system for detecting residual living virus compared with tongue inoculation of cattle, because larger volumes can be tested.
The next aspect of the use of cell cultures in testing virus vaccines is the search for extraneous agents. There are three approaches to the problem of adventitious agents in cell cultures: quarantined free-living animals; enclosed flocks; and pedigreed cell strains. The use of quarantined animals has not proved satisfactory, because too many viral agents remain latent in cells and emerge readily in culture.
Enclosed specific pathogen-free (SPF) colonies, on the other hand, have proved very valuable. The most used examples are chickens, for a range of animal and human viruses (distemper, poultry vaccines, measles, living influenza), and ducks and rabbits for rubella vaccines. The monitoring of these enclosed colonies is a formidable undertaking, as illustrated by the tests required for the maintenance of an SPF chicken colony (Table 1) . The third type of cell is a cell strain, for example, the human diploid cell strains W138 and MRC5. These cells enable a seed lot system to be used for the substrate for virus production, as well as for the virus seed to be used for vaccine production. WI38 cells have been used for oral poliomyelitis and rubella vaccine and MRC5 for oral poliovaccine. There have been no isolations of extraneous viruses in tests in animals or cell cultures, nor have any viruses been seen by electron microscopy, which has proved to be a remarkably sensitive technique. Our experience with these cells is summarized in Tables 2 & 3. The major problem is the number of tests that have to be repeated for technical reasons, and I believe a case could be made for reducing the amount of testing for extraneous agents when a proven system is being used. The main remaining source of adventitious agents is serum. This is usually calf serum, which is comprehensively tested but, nonetheless, some surprises occur, especially from three viruses: reoviruses, bovine papillomatosis and bovine viral diarrhoea (Nuttall et al. 1977) , but is readily destroyed by heating at 56°C for half an hour. Cell cultures are also used to titrate the virus and to determine its purity by plaqueing. For example, the plaque type can be used to recognize parental properties in recombinants used as living influenza vaccines (Figure 2) . The methods are also very much more reliable and efficient for the titration of viruses. Yellow fever virus, for example, can be more accurately and economically titrated in cell culture than in mice (Table 4 ).
